---
title: "Everest Medicines gibt Termin für außerordentliche Hauptversammlung bekannt"
description: "Everest Medicines Ltd. will hold an extraordinary general meeting on February 22, 2026, as a virtual session. The agenda includes the approval of ongoing connected transactions related to the Commerci"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274623756.md"
published_at: "2026-02-03T08:43:11.000Z"
---

# Everest Medicines gibt Termin für außerordentliche Hauptversammlung bekannt

> Everest Medicines Ltd. will hold an extraordinary general meeting on February 22, 2026, as a virtual session. The agenda includes the approval of ongoing connected transactions related to the Commercialization Service Agreement, proposed allocation of shares to a connected person, application for a waiver of certain requirements, and the planned introduction of the 2026 Share Scheme. This information was published via the Issuer Information Service by the Hong Kong Stock Exchange.

Everest Medicines Ltd. hält am 22. Februar 2026 eine außerordentliche Hauptversammlung als virtuelle Sitzung ab. Auf der Tagesordnung stehen unter anderem die Genehmigung fortlaufender verbundener Transaktionen im Zusammenhang mit dem Commercialization Service Agreement, die vorgeschlagene Zuteilung von Aktien an eine verbundene Person, die Beantragung eines Verzichts auf bestimmte Anforderungen sowie die geplante Einführung des 2026 Share Scheme. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everest Medicines Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260203-12011248), on February 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [01952.HK - EVEREST MED](https://longbridge.com/en/quote/01952.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Everest Medicines Executives Buy Shares | Everest Medicines Executives Buy Shares | [Link](https://longbridge.com/en/news/269660485.md) |
| Everest Medicines Says Chairman Purchases 30,000 Shares For HK$1.139 Million | Everest Medicines Ltd :CHAIRMAN PURCHASES 30,000 SHARES FOR HK$1.139 MILLION | [Link](https://longbridge.com/en/news/271202527.md) |
| HKEX Cancels Space Group Holdings Listing Effective Feb. 26, 2026 | Space Group Holdings Ltd. will be delisted from the Stock Exchange of Hong Kong on February 26, 2026, due to failure to  | [Link](https://longbridge.com/en/news/276580430.md) |
| Cbrain Expects EBT To Be In Range Of 20-25% In 2026 | Cbrain A/S :CBRAIN UPGRADES EARNINGS EXPECTATIONS FOR THE FINANCIAL YEAR 20262026 OUTLOOK: EXPECTS EARNINGS BEFORE TAX ( | [Link](https://longbridge.com/en/news/276312285.md) |
| Vend Marketplaces Sets New Interest Rate for VEND02 Bond at 4.97% for Feb–May 2026 | Vend Marketplaces ASA has announced a new interest rate of 4.97% for its bond NO0011157323 (VEND02) for the period from  | [Link](https://longbridge.com/en/news/276600566.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.